ExCellThera’s ECT-001 cell therapy for patients with blood cancers and disorders requiring stem cell transplants has received a Priority Medicines designation from the European Medicines Agency (EMA).
Advanced Code injection
ExCellThera’s ECT-001 cell therapy for patients with blood cancers and disorders requiring stem cell transplants has received a Priority Medicines designation from the European Medicines Agency (EMA).